Veterinary Medicines

EURICAN LR

Authorised
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Rabies virus, strain G52, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
Download as PDF

Product identification

Medicine name:
EURICAN LR
Active substance:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Rabies virus, strain G52, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
  • Rabies virus, strain G52, Inactivated
    1.00
    international unit(s)
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/7075992 3/1987
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download